Insider Transactions in Q4 2021 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
1,200
-1.1%
|
$57,600
$48.5 P/Share
|
|
Dec 22
2021
|
Jeffrey Eisele Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-1.19%
|
$4,183
$47.82 P/Share
|
|
Dec 22
2021
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
10,571
-3.16%
|
$507,408
$48.05 P/Share
|
|
Dec 22
2021
|
David O. Watson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,112
+4.41%
|
$281,568
$14.4 P/Share
|
|
Dec 15
2021
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.45%
|
$126,000
$42.88 P/Share
|
|
Dec 15
2021
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.44%
|
$6,000
$2.67 P/Share
|
|
Dec 15
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
375
-0.53%
|
$15,750
$42.88 P/Share
|
|
Dec 08
2021
|
Federico Grossi Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+8.96%
|
$21,000
$3.76 P/Share
|
|
Dec 01
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
375
-0.58%
|
$15,750
$42.4 P/Share
|
|
Nov 18
2021
|
Morningside Venture Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+1.91%
|
$10,000,000
$40.0 P/Share
|
|
Nov 15
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
625
-0.96%
|
$26,875
$43.5 P/Share
|
|
Nov 15
2021
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.45%
|
$129,000
$43.5 P/Share
|
|
Nov 15
2021
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.44%
|
$6,000
$2.67 P/Share
|
|
Nov 04
2021
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.45%
|
$105,000
$35.0 P/Share
|
|
Nov 04
2021
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.44%
|
$6,000
$2.67 P/Share
|
|
Nov 01
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
625
-0.96%
|
$18,750
$30.7 P/Share
|
|
Oct 26
2021
|
Victoria L. Brown Program Team Lead |
BUY
Grant, award, or other acquisition
|
Direct |
882
+7.17%
|
-
|
|
Oct 20
2021
|
Mark Jeffrey De Long Chief Business & Strat Officer |
BUY
Grant, award, or other acquisition
|
Direct |
882
+7.84%
|
-
|
|
Oct 20
2021
|
James George Chopas VP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
882
+9.42%
|
-
|
|
Oct 14
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
750
-1.13%
|
$25,500
$34.57 P/Share
|
|
Oct 01
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
750
-1.12%
|
$24,750
$33.26 P/Share
|